Psyence Biomedical PBM
NASDAQ PBM
$4.52 +0.28 (+6.60%)
At close: Oct 21, 2026 · 4:00 PM EDT

Psyence Biomedical (PBM) Enterprise Value (2023 - 2026)

Updated

Psyence Biomedical (PBM) reported Enterprise Value of -$6.09 million for the quarter ended Mar 31, 2026.

Analysis

Psyence Biomedical (PBM) Enterprise Value (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Psyence Biomedical 2.50 Mn -20.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.09 Mn
Sep 30, 2025 -3.29 Mn
Mar 31, 2025 -343,853.50
Sep 30, 2024 38.95 Mn
Mar 31, 2024 465.38 Mn
Sep 30, 2023 34.59 Bn
Mar 31, 2023 24.95 Bn
API Access

Psyence Biomedical Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=PBM&period=max&api_key=YOUR_API_KEY